Evidence map›Paper›PMID 32134481›Full record

ReviewThe Journal of infectious diseases2020

Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.

Hunter K Roark, Jennifer A Jenks, Sallie R Permar, Mark R Schleiss

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Animal models of human herpesvirus infection.Animal models and experimental medicine · 2025
    Review
  13. Review
  14. Oral Vaccination with AttenuatedPathogens (Basel, Switzerland) · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Immune surveillance of cytomegalovirus in tissues.Cellular & molecular immunology · 2024
    Review
  20. Pathogenesis of viral infections during pregnancy.Clinical microbiology reviews · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Hunter K RoarkDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.
Jennifer A JenksDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.
Sallie R PermarDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.
Mark R SchleissCenter for Infectious Diseases and Microbiology Translational Research, University of Minnesota Medical School, Department of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Minneapolis, Minnesota, USA.
Duke Medical Center · USUniversity of Minnesota Medical Center · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
Virology CoreP01AI129859 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI Sallie R. Permar · 2019 to 2026
$31.0M
Optimizing Immunity and Maternal Host Defense Against Congenital Cytomegalovirus InfectionR01HD098866 · NICHD · UNIVERSITY OF MINNESOTA · PI Craig John Bierle, Michael A McVoy · 2019 to 2026
$3.9M
Maternal immune protection against congenital CMV infectionDP2HD075699 · NICHD · DUKE UNIVERSITY · PI PERMAR, SALLIE R. · 2012 to 2017
$2.8M
Preclinical Evaluation of a Novel rLCMV Single-Cycle Vectored CMV VaccineR56AI114013 · NIAID · UNIVERSITY OF MINNESOTA · PI SCHLEISS, MARK R. · 2015 to 2015
$342k
ELISPOT Peptide Mapping Assay to Identify Novel Candidate CMV Vaccine AntigensR03HD082273 · NICHD · UNIVERSITY OF MINNESOTA · PI SCHLEISS, MARK R. · 2015 to 2016
$151k
NIAID NIH HHS P01 AI129859NIAID NIH HHS R56 AI114013NICHD NIH HHS DP2 HD075699NICHD NIH HHS R01 HD098866NICHD NIH HHS R03 HD082273NIGMS NIH HHS T32 GM007171
6 · The paper itself

Abstract

Although cytomegaloviruses (CMVs) are species-specific, the study of nonhuman CMVs in animal models can help to inform and direct research aimed at developing a human CMV (HCMV) vaccine. Because the driving force behind the development of HCMV vaccines is to prevent congenital infection, the animal model in question must be one in which vertical transmission of virus occurs to the fetus. Fortunately, two such animal models-the rhesus macaque CMV and guinea pig CMV-are characterized by congenital infection. Hence, each model can be evaluated in "proof-of-concept" studies of preconception vaccination aimed at blocking transplacental transmission. This review focuses on similarities and differences in the respective model systems, and it discusses key insights from each model germane to the study of HCMV vaccines.

Indexed as

Infectious Disease Transmission, VerticalAdaptive ImmunityAnimalsAntigens, ViralBiomedical ResearchCytomegalovirusCytomegalovirus InfectionsCytomegalovirus VaccinesDisease Models, AnimalGenome, ViralGenomicsGuinea PigsHost-Pathogen InteractionsHumansImmunity, InnateImmunizationAntigens, ViralCytomegalovirus VaccinesViral ProteinsCongenital cytomegaloviruscytomegalovirus glycoproteinscytomegalovirus vaccinesguinea pig cytomegalovirusrhesus macaque cytomegalovirus

Identifiers

PMID32134481
PMCPMC7057791
OpenAlexW3009439945

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.